IAG renews 2024 cat program with US$7bn protection, adds US$67m New Zealand cover
January 4 2024 by Mithun Varkey-
SIRC: Reinsurers look to consolidate underwriting gains while tapping into fast-growing APAC
- November 11
As renewals conference season draws to a close with the Singapore event, IAN brings you the reinsurance gather's key takeaways and what they mean for upcoming renewals.
-
Skuld announces 5% general increase for 2025 renewal
- November 11
Any adjustments to the International Group of P&I Clubs excess of loss reinsurance programme will be added separately.
-
Asian specialty losses to be reflected in renewals: Swiss Re
- November 7
The reinsurer’s specialty CUO Anne Lohbeck says engineering, inherent defect, cyber and credit & surety are growth drivers for APAC specialty book.
-
Reinsurers are again looking for growth, but stability is key: Mapfre Re’s Sanchez Cea
- November 4
The reinsurer expects the market to maintain discipline in underwriting and risk selection despite the increasingly competitive market.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | The hunt for diversification and performance revitalizes appetite for Asian currency bonds
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.